- Ohr Pharmaceutical (OHRP) is up 82% on entering into a merger agreement with NeuBase Therapeutics, under which the stockholders of NeuBase would become the majority holders of the combined company.
- The combined company will change its name to “NeuBase Therapeutics, Inc.” and trading symbol on NASDAQ to “NBSE”.
- Current Ohr and NeuBase stockholders will own ~20% and ~80% of the combined company, respectively.
- The merger is subject to the approval of Ohr shareholders at a special meeting expected to occur in H1 2019.
Ohr Pharmaceutical +82% on announcing merger with Neubase Therapeutics
Recommended For You
More Trending News
About NBSE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
NBSE | - | - |
NeuBase Therapeutics, Inc. |